CEMIのチャート
CEMIの企業情報
| symbol | CEMI |
|---|---|
| 会社名 | Chembio Diagnostics Inc （ケムバイオ・ダイアグノスティクス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | 医薬品 医療関連（Health Care） |
| 概要 | 事業概要 Chembio Diagnostics Inc. (Chembio) and its subsidiary Chembio Diagnostic Systems Inc. develop manufacture market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company's products available are rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies and a multiplex rapid test for the detection of HIV and Syphilis antibodies. The HIV 1/2 rapid tests employ in-licensed and lateral flow technologies that are used with all blood matrices as samples and are manufactured in a standard cassette format a dipstick format and a barrel format. Its HIV 1/2 rapid antibody detection test incorporates the Dual Path Platform (DPP) POCT technology. The DPP HIV 1/2 Assay detects antibodies to HIV 1 and 2 in oral fluid samples as well as in all blood matrices. The Company's product pipeline includes a multiplex rapid test for earlier detection of HIV and a multiplex test that detects HIV and Syphilis specific antibodies. ケムバイオ・ダイアグノスティクスは、米国の検査製品メ―カ―。感染症を検出するポイントオブケアの診断テストを開発、製造、販売、またライセンス供与を行う。主な製品には、ヒト免疫不全ウイルス（HIV）抗体検出テスト（カセット形式、ディップスティック形式、バレル形式）、梅毒検出テスト、イヌのリ―シュマニア症検出テストなどがある。 Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. |
| 本社所在地 | 3661 Horseblock Road Medford NY 11763 USA |
| 代表者氏名 | John J. Sperzel ジョン・J.・スペルゼル |
| 代表者役職名 | President Chief Executive Officer Director 社長兼最高経営責任者（CEO） |
| 電話番号 | +1 631-924-1135 |
| 設立年月日 | 31382 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 165人 |
| url | www.chembio.com |
| nasdaq_url | https://www.nasdaq.com/symbol/cemi |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -4.13082 |
| 終値（lastsale） | 9.7 |
| 時価総額（marketcap） | 137484114 |
| 時価総額 | 時価総額（百万ドル） 136.77540 |
| 売上高 | 売上高（百万ドル） 30.01290 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 127.69617 |
| 当期純利益 | 当期純利益（百万ドル） -4.96381 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Chembio Diagnostics Inc revenues increased 57% to $16.4M. Net loss decreased 37% to $2.4M. Revenues reflect North America segment increase from $1.8M to $6M Africa segment increase from $863K to $3.9M. Lower net loss reflects Stock-based Compensation in R&D decrease of 72% to $16K (expense) Interest Income increase of 44% to $30K (income). |
CEMIのテクニカル分析
CEMIのニュース
Biosynex Completes Acquisition of Chembio Diagnostics, Inc. 2023/04/27 20:30:00 GlobeNewswire
Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America
Brightcove And 2 Other Stocks Under $5 Insiders Are Aggressively Buying 2023/04/21 11:23:23 Benzinga
The Dow Jones closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company''s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga''s insider transactions platform. Chembio Diagnostics The Trade: Chembio Diagnostics, Inc. (NASDAQ: CEMI ) 10% owner Joseph Edelman acquired a total 208,800 shares an average price of $0.45. To acquire these … Full story available on Benzinga.com
Gold Down 2%; Citigroup Earnings Top Estimates 2023/04/14 19:11:04 Benzinga
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 200 points on Friday. The Dow traded down 0.58% to 33,831.25 while the NASDAQ fell 0.58% to 12,095.62. The S&P 500, also fell, dropping, 0.41% to 4,129.34. Check This Out: Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying Leading and Lagging Sectors Financials shares rose by 0.8% on Friday. Meanwhile, top gainers in the sector included JPMorgan Chase & Co. (NYSE: JPM ), up 7%, and X Financial (NYSE: XYF ), up 7%. In trading on Friday, real estate fell by 1.5%. Top Headline Citigroup Inc (NYSE: C ) reported strong Q1 results. Citigroup reported first-quarter FY23 net revenue growth of 12% year-over-year to $21.45 billion, beating the consensus of $20.03 billion. EPS for Q1 was $2.19, above the consensus of $1.67. Equities Trading UP My Size, Inc. (NASDAQ: MYSZ ) shares shot up 14% to $1.6850 after the company said FY22 consolidated revenue jumped 3304% to $4.459 million.
Dow Dips Over 150 Points; JPMorgan Posts Upbeat Results 2023/04/14 16:00:06 Benzinga
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 150 points on Friday. The Dow traded down 0.53% to 33,850.38 while the NASDAQ fell 0.59% to 12,094.01. The S&P 500, also fell, dropping, 0.30% to 4,133.89. Check This Out: Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying Leading and Lagging Sectors Financials shares rose by 1.2% on Friday. Meanwhile, top gainers in the sector included JPMorgan Chase & Co. (NYSE: JPM ), up 7%, and Deutsche Bank Aktiengesellschaft (NYSE: DB ), up 4%. In trading on Friday, utilities fell by 0.6%. Top Headline JPMorgan Chase & Co (NYSE: JPM ) reported better-than-expected results for its first quarter on Friday. The bank reported Q1 net revenue (managed) of $39.3 billion, up 25% Y/Y, beating the consensus of $36.2 billion. EPS of $4.10 beat the consensus of $3.41. Equities Trading UP My Size, Inc. (NASDAQ: MYSZ ) shares shot up 34% to $1.98 after the company said FY22 consolidated revenue jumped 3304% to $4.459 million.
US Stocks Mixed; Retail Sales Drop 1% In March 2023/04/14 13:50:02 Benzinga
U.S. stocks traded mixed this morning, following the release of economic reports. Following the market opening Friday, the Dow traded up 0.08% to 34,055.40 while the NASDAQ fell 0.10% to 12,153.84. The S&P 500, also rose, gaining, 0.13% to 4,151.57. Check This Out: Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying Leading and Lagging Sectors Financials shares rose by 1.2% on Friday. Meanwhile, top gainers in the sector included JPMorgan Chase & Co. (NYSE: JPM ), up 7%, and Deutsche Bank Aktiengesellschaft (NYSE: DB ), up 4%. In trading on Friday, utilities fell by 0.6%. Top Headline Retail sales in the US dropped 1% month-over-month in March versus a revised 0.2% decline in February. Equities Trading UP CXApp Inc. (NASDAQ: CXAI ) shares shot up 140% to $17.10 after gaining more than 345% on Thursday. Shares of Purple Innovation, Inc. (NASDAQ: PRPL ) got a boost, shooting 21% to $2.7093. Purple Innovation announced cooperative framework with Coliseum Capital.
Biosynex Completes Acquisition of Chembio Diagnostics, Inc. 2023/04/27 20:30:00 GlobeNewswire
Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America
Brightcove And 2 Other Stocks Under $5 Insiders Are Aggressively Buying 2023/04/21 11:23:23 Benzinga
The Dow Jones closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company''s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga''s insider transactions platform. Chembio Diagnostics The Trade: Chembio Diagnostics, Inc. (NASDAQ: CEMI ) 10% owner Joseph Edelman acquired a total 208,800 shares an average price of $0.45. To acquire these … Full story available on Benzinga.com
Gold Down 2%; Citigroup Earnings Top Estimates 2023/04/14 19:11:04 Benzinga
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 200 points on Friday. The Dow traded down 0.58% to 33,831.25 while the NASDAQ fell 0.58% to 12,095.62. The S&P 500, also fell, dropping, 0.41% to 4,129.34. Check This Out: Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying Leading and Lagging Sectors Financials shares rose by 0.8% on Friday. Meanwhile, top gainers in the sector included JPMorgan Chase & Co. (NYSE: JPM ), up 7%, and X Financial (NYSE: XYF ), up 7%. In trading on Friday, real estate fell by 1.5%. Top Headline Citigroup Inc (NYSE: C ) reported strong Q1 results. Citigroup reported first-quarter FY23 net revenue growth of 12% year-over-year to $21.45 billion, beating the consensus of $20.03 billion. EPS for Q1 was $2.19, above the consensus of $1.67. Equities Trading UP My Size, Inc. (NASDAQ: MYSZ ) shares shot up 14% to $1.6850 after the company said FY22 consolidated revenue jumped 3304% to $4.459 million.
Dow Dips Over 150 Points; JPMorgan Posts Upbeat Results 2023/04/14 16:00:06 Benzinga
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 150 points on Friday. The Dow traded down 0.53% to 33,850.38 while the NASDAQ fell 0.59% to 12,094.01. The S&P 500, also fell, dropping, 0.30% to 4,133.89. Check This Out: Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying Leading and Lagging Sectors Financials shares rose by 1.2% on Friday. Meanwhile, top gainers in the sector included JPMorgan Chase & Co. (NYSE: JPM ), up 7%, and Deutsche Bank Aktiengesellschaft (NYSE: DB ), up 4%. In trading on Friday, utilities fell by 0.6%. Top Headline JPMorgan Chase & Co (NYSE: JPM ) reported better-than-expected results for its first quarter on Friday. The bank reported Q1 net revenue (managed) of $39.3 billion, up 25% Y/Y, beating the consensus of $36.2 billion. EPS of $4.10 beat the consensus of $3.41. Equities Trading UP My Size, Inc. (NASDAQ: MYSZ ) shares shot up 34% to $1.98 after the company said FY22 consolidated revenue jumped 3304% to $4.459 million.
US Stocks Mixed; Retail Sales Drop 1% In March 2023/04/14 13:50:02 Benzinga
U.S. stocks traded mixed this morning, following the release of economic reports. Following the market opening Friday, the Dow traded up 0.08% to 34,055.40 while the NASDAQ fell 0.10% to 12,153.84. The S&P 500, also rose, gaining, 0.13% to 4,151.57. Check This Out: Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying Leading and Lagging Sectors Financials shares rose by 1.2% on Friday. Meanwhile, top gainers in the sector included JPMorgan Chase & Co. (NYSE: JPM ), up 7%, and Deutsche Bank Aktiengesellschaft (NYSE: DB ), up 4%. In trading on Friday, utilities fell by 0.6%. Top Headline Retail sales in the US dropped 1% month-over-month in March versus a revised 0.2% decline in February. Equities Trading UP CXApp Inc. (NASDAQ: CXAI ) shares shot up 140% to $17.10 after gaining more than 345% on Thursday. Shares of Purple Innovation, Inc. (NASDAQ: PRPL ) got a boost, shooting 21% to $2.7093. Purple Innovation announced cooperative framework with Coliseum Capital.
Chembio Diagnostics, Inc. (CEMI) CEO Rick Eberly on Q1 2022 Results - Earnings Call Transcript 2022/05/08 13:21:32 Seeking Alpha
Chembio Diagnostics, Inc. (NASDAQ:NASDAQ:CEMI) Q1 2022 Earnings Conference Call May 5, 2022 04:30 PM ET Company Participants Rick Eberly - President & Chief Executive Officer Larry…
Chembio Diagnostics GAAP EPS of -$0.29 misses by $0.08, revenue of $18.82M beats by $7.02M 2022/05/05 20:19:39 Seeking Alpha
Chembio Diagnostics press release (CEMI): Q1 GAAP EPS of -$0.29 misses by $0.08.Revenue of $18.82M (+115.8% Y/Y) beats by $7.02M.
Chembio Diagnostics Reports First Quarter 2022 Financial Results 2022/05/05 20:05:00 GlobeNewswire
HAUPPAUGE, N.Y., May 05, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended March 31, 2022.
Chembio Diagnostics to Report First Quarter 2022 Financial Results on May 5, 2022 2022/04/21 20:05:00 GlobeNewswire
HAUPPAUGE, N.Y., April 21, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the first quarter of 2022 after the close of trading on Thursday, May 5, 2022.
Chembio Diagnostics Inc. (NASDAQ: CEMI) Shares Fall By 8.53 Percent In The Past Week, But How Long Will It Last? 2022/03/26 17:00:00 Marketing Sentinel
Chembio Diagnostics Inc. (NASDAQ:CEMI)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 1.68. At the close of trading, the stock’s price was $0.88, to imply an increase of 0.78% or $0.01 in intraday trading. The CEMI share’s 52-week high remains $7.34, putting it -734.09% down since that … Chembio Diagnostics Inc. (NASDAQ: CEMI) Shares Fall By 8.53 Percent In The Past Week, But How Long Will It Last? Read More »